nivolumab,ipilimumab,pembrolizumab,lenvatinib,Cabozantinib
merck,bms,Eisai
['nivo', '/ipi', 'kn-b61', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)']
 : 1) phii kn-b61 #1l len + pembro adv #nccrcc 49% orr (6% cr), med dor nr &amp; pfs 17.9 mos, 2) #imdc study #1l io-based tx s &gt; vegf-tkis in sarc/rhabdoid nccrcc, 3) phii #1l cabo/nivo/ipi 18% orr &amp; high g3/4 aes doublet likely &gt; triplet in nccrcc #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope